Chemical exposure
Phthalates, insulin resistance, and race gaps
Open access · cc by · source: Europe PMC
In NHANES 2001–2008, several urinary phthalates tracked higher glucose and HOMA-IR, with stronger signals in Mexican-Americans than whites.
Study at a glance
- Design
- Cross-sectional — NHANES 2001–2008 phthalate metabolites vs fasting glucose/HOMA-IR by sex and race/ethnicity
- N
- N=3083 · 3,083 nondiabetic participants aged 12–<80
- Population
- Nondiabetic US NHANES participants
- Outcome
- Fasting glucose, insulin, and HOMA-IR associated with urinary phthalates
Structured fields used in claim comparison tables when every cited study has a complete layer.
Key findings
Women had higher creatinine-adjusted phthalates; MnBP, MiBP, MCPP, and ΣDEHP associated with diabetes-risk markers; MiBP’s top quartile raised median FBG 5.82 mg/dL in Mexican-Americans versus a nonsignificant 1.79 in whites.
Methodology
Linked 8 urinary phthalate metabolites to fasting glucose, insulin, and HOMA-IR in 3,083 nondiabetic NHANES participants aged 12–<80, stratified by gender and race/ethnicity.
Limitations
Cross-sectional one-spot urine cannot prove causation or capture long-term phthalate exposure.
How this study connects
Role on claims
Each row is a claim on a concept or method page where this paper supports, challenges, or qualifies the statement. Roles are hand-checked — not a model guess.
In 3,083 nondiabetic NHANES participants aged 12–<80, women had higher creatinine-adjusted phthalates; MnBP, MiBP, MCPP and ΣDEHP associated with diabetes-risk markers. MiBP's top quartile raised median fasting glucose 5.82 mg/dL in Mexican-Americans versus a nonsignificant 1.79 mg/dL in whites — a stratified association, not a universal slope.
Evidence for the claim as stated.
Urinary phthalate papers disagree on what a metabolite gap means. Douching frequency tracks MEP (51.6% and 152.2% higher) as a disparity pathway; HOMA-IR-related associations differ by race/ethnicity (MiBP fasting-glucose 5.82 vs 1.79 mg/dL); Egyptian urban medians do not match US MBzP. Spot urine plus self-report cannot prove a single product brand caused the pattern.
Evidence for the claim as stated.
Open questions
Tensions this paper is part of
From concept pages' “where studies disagree.” Disagreement means the same question; scope means different assays, populations, or outcomes.
Urinary phthalate papers disagree on what a metabolite gap means. Douching frequency tracks MEP (51.6% and 152.2% higher) as a disparity pathway; HOMA-IR-related associations differ by race/ethnicity (MiBP fasting-glucose 5.82 vs 1.79 mg/dL); Egyptian urban medians do not match US MBzP. Spot urine plus self-report cannot prove a single product brand caused the pattern.
- Supports · Douching helps explain MEP disparities
- Supports · Phthalates in Egyptian premenstrual girls
Related papers in this topic
Same topic cluster — not a recommendation engine.